These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7021 related articles for article (PubMed ID: 23122307)

  • 1. Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression.
    Zhang Q; Yuan WF; Zhai GQ; Zhu SY; Xue ZF; Zhu HF; Xu XM
    Biomed Environ Sci; 2012 Oct; 25(5):509-16. PubMed ID: 23122307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
    Kurooka M; Kaneda Y
    Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticancer immunotherapy using inactivated Sendai virus particles].
    Kurooka M; Kaneda Y
    Uirusu; 2007 Jun; 57(1):19-27. PubMed ID: 18040151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Sendai virus induces apoptosis mediated by reactive oxygen species in murine melanoma cells.
    Gao H; Li LY; Zhang M; Zhang Q
    Biomed Environ Sci; 2016 Dec; 29(12):877-884. PubMed ID: 28081748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated Sendai virus strain Tianjin, a novel genotype of Sendai virus, inhibits growth of murine colon carcinoma through inducing immune responses and apoptosis.
    Shi L; Chen J; Zhong Q; Li M; Geng P; He J; Han Z; Sheng M; Tang H
    J Transl Med; 2013 Sep; 11():205. PubMed ID: 24007528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus.
    Gao H; Gong XC; Chen ZD; Xu XS; Zhang Q; Xu XM
    Biomed Environ Sci; 2014 Jul; 27(7):506-14. PubMed ID: 25073909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production.
    Saga K; Tamai K; Yamazaki T; Kaneda Y
    Clin Cancer Res; 2013 Feb; 19(3):668-79. PubMed ID: 23251005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application.
    Tanemura A; Kiyohara E; Katayama I; Kaneda Y
    Cancer Gene Ther; 2013 Nov; 20(11):599-605. PubMed ID: 24157924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice.
    Nishikawa T; Tung LY; Kaneda Y
    Mol Ther; 2014 Dec; 22(12):2046-2055. PubMed ID: 25023327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus.
    Zhang Q; Xu X; Yuan Y; Gong X; Chen Z; Xu X
    Int J Cancer; 2014 Jan; 134(1):224-34. PubMed ID: 23784981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.
    Takehara Y; Satoh T; Nishizawa A; Saeki K; Nakamura M; Masuzawa M; Kaneda Y; Katayama I; Yokozeki H
    Clin Immunol; 2013 Oct; 149(1):1-10. PubMed ID: 23886549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice].
    Shi L; Chen J; Zhong Q; Geng P; He J
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):177-82. PubMed ID: 24785276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
    Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A
    Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity.
    Chang CY; Tai JA; Li S; Nishikawa T; Kaneda Y
    Oncotarget; 2016 Jul; 7(27):42195-42207. PubMed ID: 27259252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.
    Matsuda M; Nimura K; Shimbo T; Hamasaki T; Yamamoto T; Matsumura A; Kaneda Y
    J Neurooncol; 2011 May; 103(1):19-31. PubMed ID: 20730616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
    Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
    Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation.
    Fujihara A; Kurooka M; Miki T; Kaneda Y
    Cancer Immunol Immunother; 2008 Jan; 57(1):73-84. PubMed ID: 17602226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells.
    Li S; Nishikawa T; Kaneda Y
    Cancer Sci; 2017 Dec; 108(12):2333-2341. PubMed ID: 28945328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine.
    Zhang Q; Wang Z; Yuan Y; Xue Z; Zhai G; Zuo W; Zhu S; Zhu G; Xu X
    Vet Immunol Immunopathol; 2011 May; 141(1-2):116-23. PubMed ID: 21444118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.
    Jiang Y; Saga K; Miyamoto Y; Kaneda Y
    Oncotarget; 2016 Jun; 7(24):36034-36048. PubMed ID: 27145280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 352.